HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (11) Citing Articles via Google Scholar Google Scholar Articles by Carrozza, J. P. Search for Related Content PubMed PubMed Citation Articles by Carrozza, J. P., Jr

Randomized Evaluation of the TriActiv Balloon-Protection Flush and Extraction System for the Treatment of Saphenous Vein Graft Disease

Joseph P. Carrozza, Jr, MD, FACC^_*,_*, Michael Mumma, MD, FACC, Jeffrey A. Breall, MD, PhD, FACC, Aland Fernandez, MD, FACC, Eugene Heyman, PhD^||, Christopher Metzger, MD, FACC^¶ for the PRIDE Study Investigators

^_* Section of Interventional Cardiology-Beth Israel Deaconess Medical Center, Boston, Massachusetts USA
Sarasota Memorial Hospital, Sarasota, Florida USA
Krannert Institute of Cardiology, Indiana University of Medicine, Indianapolis, Indiana USA
Morton Plant Hospital, Clearwater Cardiovascular & Interventional Consultants, Clearwater, Florida USA
^|| Montgomery Village, Maryland USA
^¶ Wellmont Holston Valley Medical Center, Kingsport, Tennessee USA.

View larger version (17K): [in a new window]   Figure 1 Enrollment in the PRIDE study.

View larger version (26K): [in a new window]   Figure 2 (A) Post-treatment creatine kinase (CK)-MB and (B) total creatine phosphokinase (CPK) elevation according to embolic protection system used. ULN = upper limit of normal.

View larger version (12K): [in a new window]   Figure 3 Vascular/hemorrhagic complications according to treatment assignment and catheter size.